Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Accurate expert analysis for a fragmented market

timely news deep insight pharma intelligence

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

See how we can help you get ahead in the competitive medtech environment: watch the video

Relevant products

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

Real-time news and analysis
Regulatory development news
Company development news

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

Real-time market intelligence
Medical device market coverage
Discover new opportunities

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

Medtech Insight

New Device Tax Repeal Bills Are Coming, With Candidate Klobuchar's Help

By Ferdous Al-Faruque 14 Feb 2019

Despite a recent report that Sen. Amy Klobuchar, D-Minn., is backing away from leading efforts to repeal the medical device tax due to her presidential ambitions, sources say she is working with Sen. Pat Toomey, R-Pa., to cosponsor a repeal bill this year. Similarly, on the US House-side, Rep. Ron Kind, D-Wisc., is calling on his colleagues to support a full repeal bill as well.

Topic Medtech

View article
Medtech Insight

One In Three Medtech Innovators Will Be 'Driven Out Of Business' By EU MDR, German Business Survey Finds

By Ashley Yeo 14 Feb 2019

The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.

Topic Medtech

View article
Medtech Insight

BSI Touts Very Short Waiting Times For Migrating Certificates From UK To Netherlands

By Amanda Maxwell 07 Feb 2019

With a growing urgency for medtech manufacturers to take decisive action so their products are not banned from the market under an increasingly likely no-deal Brexit, clients of BSI will be relieved to hear their notified body believes time is on their side.

Topic Medtech

View article
Medtech Insight

US Homeland Security: Stryker, BD Devices Pose Hacking Risk

By Elizabeth Orr 07 Feb 2019

The US Department of Homeland Security National Cybersecurity and Communications Integration Center is warning of potential cybersecurity vulnerabilities in Stryker hospital beds and BD diagnostics equipment.

View article
In Vivo

David Or Goliath: Where Is Innovation Winning Through?

By Lucie Ellis 01 Feb 2019

With both a big pharma and biotech leadership perspective, David Meeker talks to In Vivo about how smaller firms can more easily fly solo in drug development, challenges effecting the innovative drug development sector in 2019 and the partnering environment for cell and gene therapy companies.

Topic BioPharmaceutical Drug approval Drug development landscape Drug review

View article
Medtech Insight

MDSAP Is A Snap If Your Firm Follows Quality Systems Standard ISO 13485, Auditor Says

By Shawn M. Schmitt 01 Feb 2019

NSF International's Brian Ludovico explains why device-makers that already follow international quality systems standard ISO 13485 shouldn't be nervous about taking part in the Medical Device Single Audit Program. Ludovico also shares MDSAP participation numbers and says firms should feel at ease knowing that the program's auditing organizations undergo a rigorous process to become recognized by the MDSAP Regulatory Authority Council.

View article
Medtech Insight

Bumps In The Road As US FDA Tries To Catch Up From Shutdown

By David Filmore 01 Feb 2019

The recently ended record-setting US government shutdown is not anticipated to have a long-term impact on US FDA device review times. But agency reviewers will face more 510(k) review deadline pressures than usual and may have limited availability for pre-submission meetings in the short term, one expert suggests.

Topic FDA US Shutdown

View article
Medtech Insight

US Federal Courts Can Operate Until Jan. 31; Patent Office Faces Imminent Closure Under Shutdown

By Brenda Sandburg 28 Jan 2019

Federal courts and the US Patent and Trademark Office will soon run out of funds that have allowed them to continue normal operations under the partial government shutdown so far.

Topic US Shutdown

View article
Medtech Insight

Standards, Not Predicates Emphasized In Finalized Alternative 510(k) Pathway

By Elizabeth Orr 23 Jan 2019

Despite pushback from industry, US FDA has moved forward with plans to establish a new alternative 510(k) pathway by finalizing a guidance document that describes the so-called “Safety and Performance Based Pathway” that emphasizes use of consensus standards instead of direct predicate comparisons.

Topic FDA

View article
Medtech Insight

EU Beats Predicted Timelines And Appoints First UK Notified Body Against MDRl

By Amanda Maxwell 23 Jan 2019

There had been warnings that the first notified bodies would not be designated by the European Commission until late July 2019, 10 months before the full application of the EU Medical Device Regulation. But now that BSI is the first notified body in the EU to be designated under the MDR, are things looking up?

Topic Medtech

View article
Medtech Insight

NZ To Replace Outdated And Piecemeal Device Rules

16 Jan 2019

There are significant changes in store for New Zealand’s medical device sector, including a new regulator and a set of pre- and post-market regulatory controls.

Topic Medtech

View article
Medtech Insight

About Three Months Worth Of Carryover Device Fees Remaining FDAs Gottlieb Says

By David Filmore 16 Jan 2019

US FDA has about three months' worth of medical device carryover user-fee funds to burn if the partial federal government shutdown continues, although the agency is still finalizing its shutdown balance sheet, Commissioner Scott Gottlieb says.

Topic FDA

View article
In Vivo

You May Be Making These Drug Forecasting Mistakes

By Alex Chiang + Adrian Watson 15 Jan 2019

What are the top 10 most common drug forecasting errors, and how can these be avoided? Life sciences consulting firm, Trinity Partners, explores the ins and outs of forecasting.

Topic Drug approval Drug review

View article
In Vivo

Clinical Trials In 2019: Is Biopharma Ready To Tackle The Iron Triangle of Time, Cost and Quality?

By William Looney 10 Jan 2019

The clinical trial embodies the hope and the hassle of biopharma’s mission to develop new drugs for patients. It is an endlessly imperfect process: C-suite calls for more efficiency and speed at lower cost has been the story for decades. But an In Vivo conversation with a leading expert on trial management pinpoints three key trends that suggest better days are ahead for this central pillar of the innovation imperative.

Topic Clinical trials

View article
Medtech Insight

UK To Demand 'Responsible Person' Be Physically Located In Country Under No-Deal Brexit

By Amanda Maxwell 10 Jan 2019

The recent no-deal Brexit notice from the UK government says that companies selling devices in the UK would need a "Responsible Person" in the UK if the firm is not based there. The government clarifies to Medtech Insight that such person must be physically present in the UK, and not simply have an address there.

Topic Brexit

View article

Latest headlines

Medtech Insight

15 Feb 2019

QUOTED. Feb. 15, 2019. Larry Biegelsen.

Link
Medtech Insight

15 Feb 2019

Trade Group Suggests New Guidelines On Imaging Device Servicing, Remanufacturing

Link
Medtech Insight

15 Feb 2019

Medtronic Plans To Issue Software Fix In Second Half Of 2019 Following Pulse Generator Recall

Link
Medtech Insight

15 Feb 2019

FDA Draft Guidance Outlines Agency's Plan To Offer Nonbinding Feedback On Form-483 Observation Resolutions

Link
Medtech Insight

15 Feb 2019

Breast Surgeons Advise All Breast Cancer Patients Be Offered Genetic Testing

Link
Medtech Insight

15 Feb 2019

Vagus Nerve Stim Gets New Chance To Prove Its Worth For Depression

Link
Medtech Insight

15 Feb 2019

Trump Signs 2019 US Federal Funding Bill, Stopping Another FDA Shutdown; CDRH Sees $69M Boost

Link
Medtech Insight

14 Feb 2019

QUOTED. Feb. 14, 2019. Trish Costello.

Link
Medtech Insight

14 Feb 2019

Canada Lays Out Rules On Device Importation

Link
Medtech Insight

14 Feb 2019

Software: Australia Plans Reforms While Canada Consults On Guidance

Link
Medtech Insight

14 Feb 2019

Medtech Security Organization Adopts Widely Used Automation Cybersecurity Standard

Link
Medtech Insight

14 Feb 2019

US FDA Advisory Committee Recommends 3-Year Benefit-Risk Reviews For Pelvic Mesh

Link
In Vivo

14 Feb 2019

From Device Centric To Disease Management: Ascensia Commits To Deeper Role In Diabetes

Link
Medtech Insight

14 Feb 2019

MDx Health Signs Exclusive Canadian Agreement

Link
Medtech Insight

14 Feb 2019

Medtech Tips: First-Rate Problem Statement Key To Failure Investigations, Cardinal Health Quality VP Says

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Medtech Market Intelligence

Accurate expert analysis for a fragmented market

Relevant products

Below are the Product List

Medtech Insight: global medical technology news & analysis

Meddevicetracker: medical device intelligence and forecasts

In Vivo: strategic insights for life sciences decision-makers

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store